For citations:
Abdullaev SP, Abdullaev SP, Shatokhin MN, Krasnov AV, Bochkov PO, Tuchkova SN, Loran OB, Sychev DA. Impact of CYP2D6 polymorphisms on the pharmacokinetics, efficacy, and safety of tamsulosin therapy in patients with benign prostatic hyperplasia. Meditsinskiy sovet = Medical Council. 2024;(23):244-254. (In Russ.) https://doi.org/10.21518/ms2024-478
 
                     
         
            

































 
  Email this article
            Email this article